 David Church
Concepts (196)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscle, Skeletal | 22 | 2023 | 847 | 3.300 |
Why?
| | Resistance Training | 13 | 2020 | 102 | 2.200 |
Why?
| | Muscle Proteins | 10 | 2023 | 307 | 2.070 |
Why?
| | Dietary Supplements | 15 | 2023 | 452 | 2.050 |
Why?
| | Exercise | 19 | 2021 | 547 | 2.010 |
Why?
| | Amino Acids, Essential | 5 | 2021 | 133 | 1.330 |
Why?
| | Dietary Proteins | 8 | 2021 | 230 | 1.230 |
Why?
| | Amino Acids | 5 | 2023 | 369 | 1.220 |
Why?
| | Military Personnel | 5 | 2022 | 173 | 1.160 |
Why?
| | Carnosine | 4 | 2018 | 5 | 1.110 |
Why?
| | Protein Biosynthesis | 5 | 2020 | 273 | 1.050 |
Why?
| | Athletic Performance | 4 | 2020 | 46 | 0.980 |
Why?
| | beta-Alanine | 3 | 2018 | 11 | 0.950 |
Why?
| | Muscle Contraction | 2 | 2019 | 111 | 0.800 |
Why?
| | Insulin-Like Growth Factor I | 3 | 2016 | 136 | 0.710 |
Why?
| | Young Adult | 28 | 2021 | 4313 | 0.700 |
Why?
| | Diet | 6 | 2023 | 584 | 0.700 |
Why?
| | Military Medicine | 1 | 2019 | 21 | 0.700 |
Why?
| | Muscular Atrophy | 1 | 2019 | 73 | 0.670 |
Why?
| | Stress, Physiological | 2 | 2019 | 194 | 0.670 |
Why?
| | Occupational Diseases | 1 | 2019 | 93 | 0.640 |
Why?
| | Leucine | 3 | 2023 | 113 | 0.640 |
Why?
| | Arthroplasty, Replacement, Hip | 1 | 2021 | 249 | 0.610 |
Why?
| | Cross-Over Studies | 10 | 2022 | 250 | 0.610 |
Why?
| | Polyphenols | 4 | 2018 | 55 | 0.600 |
Why?
| | TOR Serine-Threonine Kinases | 2 | 2016 | 85 | 0.580 |
Why?
| | Triterpenes | 1 | 2016 | 13 | 0.570 |
Why?
| | Multiprotein Complexes | 1 | 2016 | 30 | 0.560 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2016 | 36 | 0.560 |
Why?
| | Sarcopenia | 3 | 2021 | 83 | 0.540 |
Why?
| | Male | 38 | 2022 | 27335 | 0.540 |
Why?
| | Coffee | 1 | 2015 | 13 | 0.540 |
Why?
| | Double-Blind Method | 10 | 2021 | 742 | 0.520 |
Why?
| | Reaction Time | 1 | 2015 | 227 | 0.500 |
Why?
| | Humans | 48 | 2024 | 54304 | 0.470 |
Why?
| | Monocytes | 4 | 2018 | 156 | 0.460 |
Why?
| | Muscle Strength | 4 | 2020 | 132 | 0.450 |
Why?
| | Quadriceps Muscle | 3 | 2018 | 49 | 0.450 |
Why?
| | Phenylalanine | 3 | 2022 | 125 | 0.430 |
Why?
| | Valerates | 3 | 2017 | 31 | 0.430 |
Why?
| | Postprandial Period | 3 | 2021 | 78 | 0.420 |
Why?
| | Adult | 24 | 2022 | 14189 | 0.410 |
Why?
| | Aging | 4 | 2021 | 782 | 0.390 |
Why?
| | Infant, Premature | 2 | 2024 | 337 | 0.380 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 3 | 2017 | 40 | 0.340 |
Why?
| | Cytokines | 3 | 2017 | 677 | 0.340 |
Why?
| | Paresthesia | 2 | 2018 | 9 | 0.320 |
Why?
| | Proteins | 2 | 2022 | 376 | 0.320 |
Why?
| | Histidine | 2 | 2017 | 17 | 0.310 |
Why?
| | Eating | 4 | 2022 | 163 | 0.300 |
Why?
| | Fatigue | 2 | 2017 | 128 | 0.290 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2017 | 435 | 0.290 |
Why?
| | Exercise Test | 5 | 2019 | 151 | 0.290 |
Why?
| | Enteral Nutrition | 2 | 2024 | 135 | 0.280 |
Why?
| | Isometric Contraction | 4 | 2018 | 25 | 0.260 |
Why?
| | Insulin | 5 | 2021 | 510 | 0.250 |
Why?
| | Athletes | 3 | 2020 | 115 | 0.240 |
Why?
| | Digestion | 2 | 2020 | 51 | 0.230 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2023 | 36 | 0.230 |
Why?
| | Proteolysis | 2 | 2020 | 102 | 0.230 |
Why?
| | Nutritional Status | 2 | 2023 | 153 | 0.220 |
Why?
| | Chemokine CCL2 | 3 | 2018 | 79 | 0.210 |
Why?
| | Signal Transduction | 4 | 2020 | 1751 | 0.210 |
Why?
| | Malnutrition | 1 | 2023 | 82 | 0.210 |
Why?
| | Female | 13 | 2022 | 28457 | 0.210 |
Why?
| | Body Mass Index | 4 | 2021 | 705 | 0.200 |
Why?
| | Food Analysis | 1 | 2021 | 37 | 0.200 |
Why?
| | Infusions, Intravenous | 1 | 2021 | 231 | 0.190 |
Why?
| | Metabolism | 1 | 2020 | 28 | 0.190 |
Why?
| | Actinidia | 1 | 2020 | 6 | 0.190 |
Why?
| | Running | 2 | 2020 | 23 | 0.190 |
Why?
| | Food | 1 | 2020 | 68 | 0.190 |
Why?
| | Muscle Fatigue | 2 | 2018 | 12 | 0.190 |
Why?
| | Caloric Restriction | 1 | 2020 | 36 | 0.190 |
Why?
| | Carbohydrate Metabolism | 1 | 2019 | 31 | 0.180 |
Why?
| | Receptors, CCR2 | 2 | 2016 | 16 | 0.180 |
Why?
| | Adaptation, Physiological | 1 | 2020 | 103 | 0.180 |
Why?
| | Physical Fitness | 2 | 2016 | 68 | 0.170 |
Why?
| | Hormones | 1 | 2019 | 59 | 0.170 |
Why?
| | Testosterone | 4 | 2023 | 119 | 0.170 |
Why?
| | Kinetics | 1 | 2020 | 692 | 0.170 |
Why?
| | Proteome | 1 | 2020 | 178 | 0.170 |
Why?
| | Occupational Health | 1 | 2019 | 74 | 0.170 |
Why?
| | Patient Compliance | 2 | 2017 | 247 | 0.170 |
Why?
| | Football | 2 | 2016 | 83 | 0.160 |
Why?
| | Lactic Acid | 2 | 2016 | 90 | 0.160 |
Why?
| | Delayed-Action Preparations | 1 | 2018 | 50 | 0.160 |
Why?
| | Alzheimer Disease | 1 | 2023 | 369 | 0.160 |
Why?
| | Martial Arts | 1 | 2017 | 1 | 0.160 |
Why?
| | Receptors, Tumor Necrosis Factor, Type II | 1 | 2017 | 16 | 0.160 |
Why?
| | Cognition | 2 | 2023 | 349 | 0.150 |
Why?
| | Hand Strength | 1 | 2017 | 32 | 0.150 |
Why?
| | Glucose | 1 | 2019 | 365 | 0.150 |
Why?
| | Nutrition Assessment | 1 | 2017 | 78 | 0.150 |
Why?
| | Dietary Carbohydrates | 1 | 2017 | 90 | 0.150 |
Why?
| | Granulocytes | 1 | 2016 | 27 | 0.150 |
Why?
| | Energy Metabolism | 1 | 2019 | 305 | 0.150 |
Why?
| | Supine Position | 1 | 2016 | 33 | 0.150 |
Why?
| | Postural Balance | 1 | 2017 | 61 | 0.150 |
Why?
| | Work Capacity Evaluation | 1 | 2016 | 21 | 0.150 |
Why?
| | Physical Education and Training | 1 | 2016 | 27 | 0.150 |
Why?
| | Insulin-Like Growth Factor Binding Proteins | 1 | 2016 | 27 | 0.150 |
Why?
| | Dietary Fats | 1 | 2017 | 138 | 0.150 |
Why?
| | Patient Positioning | 1 | 2016 | 35 | 0.140 |
Why?
| | Milk Proteins | 1 | 2017 | 77 | 0.140 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2016 | 39 | 0.140 |
Why?
| | Antioxidants | 1 | 2018 | 297 | 0.140 |
Why?
| | Hydrocortisone | 4 | 2017 | 124 | 0.140 |
Why?
| | Performance-Enhancing Substances | 1 | 2015 | 4 | 0.140 |
Why?
| | Rest | 1 | 2016 | 68 | 0.140 |
Why?
| | MAP Kinase Signaling System | 1 | 2016 | 133 | 0.130 |
Why?
| | Plant Extracts | 1 | 2018 | 192 | 0.130 |
Why?
| | Quality of Life | 1 | 2021 | 922 | 0.130 |
Why?
| | Caffeine | 1 | 2015 | 76 | 0.130 |
Why?
| | NF-kappa B | 1 | 2016 | 336 | 0.120 |
Why?
| | Ultrasonography | 1 | 2016 | 486 | 0.120 |
Why?
| | Body Composition | 3 | 2022 | 347 | 0.120 |
Why?
| | Postoperative Complications | 1 | 2021 | 1035 | 0.120 |
Why?
| | Adolescent | 7 | 2020 | 6896 | 0.120 |
Why?
| | Heart Rate | 1 | 2015 | 358 | 0.120 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2017 | 1476 | 0.120 |
Why?
| | Blood Pressure | 1 | 2015 | 586 | 0.110 |
Why?
| | Blood Glucose | 1 | 2015 | 487 | 0.110 |
Why?
| | Aged | 4 | 2021 | 10054 | 0.110 |
Why?
| | Myoglobin | 3 | 2017 | 32 | 0.100 |
Why?
| | Time Factors | 4 | 2021 | 3207 | 0.100 |
Why?
| | Tyrosine | 2 | 2022 | 137 | 0.100 |
Why?
| | Middle Aged | 3 | 2021 | 13076 | 0.100 |
Why?
| | Risk Factors | 1 | 2019 | 3934 | 0.090 |
Why?
| | Meals | 2 | 2021 | 61 | 0.090 |
Why?
| | Energy Intake | 2 | 2021 | 183 | 0.090 |
Why?
| | Oxygen Consumption | 2 | 2020 | 221 | 0.080 |
Why?
| | Macrophage-1 Antigen | 2 | 2018 | 8 | 0.080 |
Why?
| | Chemokine CX3CL1 | 2 | 2018 | 9 | 0.080 |
Why?
| | Animals | 2 | 2021 | 14402 | 0.070 |
Why?
| | Creatine Kinase | 2 | 2017 | 37 | 0.070 |
Why?
| | L-Lactate Dehydrogenase | 2 | 2017 | 79 | 0.070 |
Why?
| | Leg | 2 | 2017 | 130 | 0.070 |
Why?
| | Diffusion Tensor Imaging | 2 | 2017 | 97 | 0.070 |
Why?
| | Infant, Newborn | 2 | 2024 | 2923 | 0.070 |
Why?
| | Infant | 2 | 2024 | 3832 | 0.060 |
Why?
| | Parenteral Nutrition | 1 | 2024 | 24 | 0.060 |
Why?
| | Micronutrients | 1 | 2023 | 17 | 0.060 |
Why?
| | Polyesters | 1 | 2022 | 5 | 0.050 |
Why?
| | Nutrition Surveys | 1 | 2023 | 122 | 0.050 |
Why?
| | Memory, Short-Term | 1 | 2023 | 85 | 0.050 |
Why?
| | Isotopes | 1 | 2022 | 24 | 0.050 |
Why?
| | Egg Proteins | 1 | 2021 | 19 | 0.050 |
Why?
| | Meat | 1 | 2021 | 58 | 0.050 |
Why?
| | Plant Proteins | 1 | 2021 | 73 | 0.050 |
Why?
| | Food, Fortified | 1 | 2021 | 33 | 0.050 |
Why?
| | Basal Metabolism | 1 | 2020 | 36 | 0.050 |
Why?
| | Anaerobiosis | 1 | 2020 | 15 | 0.050 |
Why?
| | Puberty | 1 | 2020 | 20 | 0.050 |
Why?
| | Growth Differentiation Factors | 1 | 2020 | 2 | 0.050 |
Why?
| | Follistatin | 1 | 2020 | 5 | 0.050 |
Why?
| | Myostatin | 1 | 2020 | 10 | 0.050 |
Why?
| | Metabolic Clearance Rate | 1 | 2019 | 75 | 0.040 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2020 | 64 | 0.040 |
Why?
| | United States | 2 | 2024 | 5204 | 0.040 |
Why?
| | Fruit | 1 | 2020 | 142 | 0.040 |
Why?
| | Acute Disease | 1 | 2019 | 403 | 0.040 |
Why?
| | Oxidation-Reduction | 1 | 2019 | 383 | 0.040 |
Why?
| | Sex Factors | 1 | 2020 | 766 | 0.040 |
Why?
| | Solubility | 1 | 2017 | 74 | 0.040 |
Why?
| | Drug Administration Schedule | 1 | 2018 | 401 | 0.040 |
Why?
| | Fluid Shifts | 1 | 2016 | 2 | 0.040 |
Why?
| | Probiotics | 1 | 2017 | 32 | 0.040 |
Why?
| | Liver | 1 | 2023 | 1226 | 0.040 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2016 | 75 | 0.040 |
Why?
| | Interleukin-8 | 1 | 2016 | 99 | 0.040 |
Why?
| | Anthropometry | 1 | 2016 | 96 | 0.040 |
Why?
| | Physical Examination | 1 | 2016 | 99 | 0.040 |
Why?
| | Physical Exertion | 1 | 2016 | 67 | 0.030 |
Why?
| | C-Reactive Protein | 1 | 2017 | 159 | 0.030 |
Why?
| | Electromyography | 1 | 2016 | 150 | 0.030 |
Why?
| | Recovery of Function | 1 | 2017 | 222 | 0.030 |
Why?
| | Physical Endurance | 1 | 2016 | 48 | 0.030 |
Why?
| | Drug Therapy, Combination | 1 | 2017 | 426 | 0.030 |
Why?
| | Interleukin-6 | 1 | 2017 | 315 | 0.030 |
Why?
| | Universities | 1 | 2016 | 163 | 0.030 |
Why?
| | Human Growth Hormone | 1 | 2015 | 51 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2016 | 114 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2016 | 634 | 0.030 |
Why?
| | Insulin Resistance | 1 | 2017 | 299 | 0.030 |
Why?
| | Administration, Oral | 1 | 2016 | 461 | 0.030 |
Why?
| | Child, Preschool | 1 | 2023 | 4161 | 0.030 |
Why?
| | Body Weight | 1 | 2016 | 574 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2016 | 1044 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2017 | 1737 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2016 | 1294 | 0.030 |
Why?
| | Inflammation | 1 | 2017 | 679 | 0.030 |
Why?
| | Apoptosis | 1 | 2018 | 1302 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2016 | 1693 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2016 | 1616 | 0.020 |
Why?
| | Child | 1 | 2020 | 7372 | 0.020 |
Why?
|
|
Church's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|